Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
24.12
+0.52 (2.20%)
At close: Mar 4, 2026, 4:00 PM EST
24.12
0.00 (0.00%)
After-hours: Mar 4, 2026, 4:43 PM EST
Arcutis Biotherapeutics Market Cap
Arcutis Biotherapeutics has a market cap or net worth of $2.99 billion as of March 4, 2026. Its market cap has increased by 100.00% in one year.
Market Cap
2.99B
Enterprise Value
2.91B
1-Year Change
100.00%
Ranking
Category
Stock Price
$24.12
Market Cap Chart
Since January 31, 2020, Arcutis Biotherapeutics's market cap has increased from $782.04M to $2.99B, an increase of 282.55%. That is a compound annual growth rate of 24.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 2.93B | -17.71% |
| Dec 31, 2025 | 3.56B | 118.17% |
| Dec 31, 2024 | 1.63B | 434.82% |
| Dec 29, 2023 | 304.85M | -66.18% |
| Dec 30, 2022 | 901.45M | -13.58% |
| Dec 31, 2021 | 1.04B | -14.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tarsus Pharmaceuticals | 3.26B |
| Denali Therapeutics | 3.18B |
| Spyre Therapeutics | 3.15B |
| Edgewise Therapeutics | 3.09B |
| IDEAYA Biosciences | 3.01B |
| Viridian Therapeutics | 3.00B |
| Catalyst Pharmaceuticals | 2.92B |
| Arcus Biosciences | 2.81B |